Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Ready to take charge of your weight and your health
Food and Drug Administration for regulatory approval under an expedited review process, orforglipron is being evaluated as a practical oral option for chronic weight management and long term maintenance Ready to Go Beyond the Basics
Across multiple STEP trials, the enrollment criteria required a BMI of 30 or higher, or 27 or higher with at least one weight-related comorbidity (excluding type 2 diabetes, which was studied separately)
The Mayo Clinic data suggests you may see up to 35% more weight loss than you would with tirzepatide alone, a difference that becomes increasingly significant over time
Int J Mol Sci 19(9):2712 Ringseis R, Keller J, Eder K (2013) Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies
However, it's expected that insurance coverage for Zepbound will expand as insurance companies update their drug coverage rules
